Are you looking for stocks that are worth to buy? Sure, we all do! Today I like to show you some of the stocks with the highest buy rating within the Dividend Growth space.
I've compiled all Dividend Achievers, stocks that have raised dividends over a period of at least 10 years without a break, and selected them by the highest analyst rating.
British American Tobacco (NYSEMKT:BTI) has a market capitalization of $96.09 billion. The company employs 89,820 people, generates revenue of $23,268.58 million and has a net income of $6,402.67 million.
British American Tobacco’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $9,488.88 million. The EBITDA margin is 40.78 percent (the operating margin is 36.21 percent and the net profit margin 27.52 percent).
Financials: The total debt represents 43.51 percent of British American Tobacco’s assets and the total debt in relation to the equity amounts to 176.30 percent. Due to the financial situation, a return on equity of 55.35 percent was realized by British American Tobacco.
Twelve trailing months earnings per share reached a value of $5.84. Last fiscal year, British American Tobacco paid $4.34 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.78, the P/S ratio is 4.17 and the P/B ratio is finally 9.69. The dividend yield amounts to 4.63 percent and the beta ratio has a value of 0.86.
 |
| Long-Term Stock Price Chart Of British American Tobacco (BTI) |
 |
| Long-Term Dividend Payment History of British American Tobacco (BTI) |
 |
| Long-Term Dividend Yield History of British American Tobacco (BTI) |
Raven Industries (NASDAQ:RAVN) has a market capitalization of $887.53 million. The company employs 1,286 people, generates revenue of $394.68 million and has a net income of $42.90 million.
Raven Industries’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $78.19 million. The EBITDA margin is 19.81 percent (the operating margin is 16.21 percent and the net profit margin 10.87 percent).
Financials: The total debt represents 0.00 percent of Raven Industries’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 18.15 percent was realized by Raven Industries.
Twelve trailing months earnings per share reached a value of $0.92. Last fiscal year, Raven Industries paid $0.48 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 24.68, the P/S ratio is 2.32 and the P/B ratio is finally 3.48. The dividend yield amounts to 2.16 percent and the beta ratio has a value of 0.69.
 |
| Long-Term Stock Price Chart Of Raven Industries (RAVN) |
 |
| Long-Term Dividend Payment History of Raven Industries (RAVN) |
 |
| Long-Term Dividend Yield History of Raven Industries (RAVN) |
Utah Medical Products (NASDAQ:UTMD) has a market capitalization of $207.11 million. The company employs 177 people, generates revenue of $40.49 million and has a net income of $11.41 million.
Utah Medical Products’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $18.02 million. The EBITDA margin is 44.51 percent (the operating margin is 36.62 percent and the net profit margin 28.17 percent).
Financials: The total debt represents 11.30 percent of Utah Medical Products’s assets and the total debt in relation to the equity amounts to 15.05 percent. Due to the financial situation, a return on equity of 20.45 percent was realized by Utah Medical Products.
Twelve trailing months earnings per share reached a value of $3.13. Last fiscal year, Utah Medical Products paid $0.98 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.48, the P/S ratio is 5.31 and the P/B ratio is finally 3.55. The dividend yield amounts to 1.78 percent and the beta ratio has a value of 0.31.
 |
| Long-Term Stock Price Chart Of Utah Medical Products (UTMD) |
 |
| Long-Term Dividend Payment History of Utah Medical Products (UTMD) |
 |
| Long-Term Dividend Yield History of Utah Medical Products (UTMD) |
J & J Snack Foods (NASDAQ:JJSF) has a market capitalization of $1.98 billion. The company employs 3,400 people, generates revenue of $919.45 million and has a net income of $71.81 million.
J & J Snack Foods’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $144.91 million. The EBITDA margin is 15.76 percent (the operating margin is 11.62 percent and the net profit margin 7.81 percent).
Financials: The total debt represents 0.07 percent of J & J Snack Foods’s assets and the total debt in relation to the equity amounts to 0.09 percent. Due to the financial situation, a return on equity of 13.31 percent was realized by J & J Snack Foods.
Twelve trailing months earnings per share reached a value of $3.82. Last fiscal year, J & J Snack Foods paid $1.12 in the form of dividends to shareholders.
Market Valuation: Here are the price ratios of the company: The P/E ratio is 27.92, the P/S ratio is 2.18 and the P/B ratio is finally 3.56. The dividend yield amounts to 1.34 percent and the beta ratio has a value of 0.66.
 |
| Long-Term Stock Price Chart Of J & J Snack Foods (JJSF) |
 |
| Long-Term Dividend Payment History of J & J Snack Foods (JJSF) |
 |
| Long-Term Dividend Yield History of J & J Snack Foods (JJSF) |
 |
| 11 Dividend Achievers With Strong Buy Rating (Click to enlarge) Source: long-term-investments.blogspot.com |
*I am long BTI. I receive no compensation to write about these specific stocks, sector or theme. I don't plan to increase or decrease positions or obligations within the next 72 hours.
For the other stocks: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.
This article was written by Dividend Yield. If you enjoyed this article, please subscribe to his feed [RSS].
